New Dedicated HCPCS Codes for MyoStrain® and MyoStress™
The codes come into effect today, July 1, 2020. Read more about the codes in our latest news release.
Read News ReleaseThe codes come into effect today, July 1, 2020. Read more about the codes in our latest news release.
Read News Release
Myocardial Solutions, Inc. (MSI), who has pioneered the quantification of segmental cardiac strain testing to transform how physicians manage and monitor patient heart health, announced today that the Centers for Medicare and Medicaid Services (CMS) has issued unique codes for MSI’s...
June 23, 2020
Myocardial Solutions, Inc. (MSI) was recognized in an article published by the CEO Views describing their selection for the “Most Innovative Companies to Watch in 2020” yearly list. The list highlights companies driving innovative technology solutions to challenge and transform the current ...
May 28, 2020
MyoStrain® was featured in the European Society of Cardiology’s (ESC) cardio-oncology webinar series to examine the role of MyoStrain in helping cardio-oncologists manage cardiac health for patients undergoing cancer therapy. As part of an educational grant sponsored by Myocardial Solutions...
April 25, 2020
Myocardial Solutions, Inc. announced today that it has hired Peter Gaccione as President effective April 13, 2020. Peter will also serve as acting VP Sales and Marketing to drive focus and increase market penetration efforts. Peter comes from Elekta where he was EVP North & Central America and...
April 21, 2020
Six new abstracts & posters showcasing MyoStrain were published as part of the American College of Cardiology’s (ACC) 69th Annual Scientific Session & Expo. The conference, which was scheduled to take place in Chicago, Illinois from March 28-30, was shifted to a virtual experience due to the...
March 31, 2020
Myocardial Solutions (MSI) enabled 16 new abstracts and five podium presentations showcasing the latest in MyoStrain insights to the Society for Cardiovascular Magnetic Resonance’s (SCMR) 23rd Annual Scientific...
February 18, 2020
A newly submitted clinical abstract utilizes MyoStrain to detect the cardiotoxic effects of Carfilzomib, a cancer therapy drug used in treating patients diagnosed with multiple myeloma.Conducted at Heidelberg University Hospital in Germany as part of an ongoing...
October 11, 2019
Last weekend, the Myocardial Solutions (MSI) team attended the European Society of Cardiology (ESC) Congress 2019 to further the discussion of MyoStrain as a unique clinical tool for helping physicians proactively detect, monitor and manage heart failure. The ESC Congress took place from August...
September 5, 2019
A new article on MyoStrain has been published in Nature Research’s recent Scientific Reports issue. Based upon an ongoing study conducted at German Heart Center Berlin (Charité University Medical Center Berlin), the article evaluates MyoStrain’s consistency in the acquisition of left ventricular...
August 21, 2019
A new article demonstrating the significant cost savings that could be achieved using MyoStrain to detect and manage early heart failure was published in Health Economics Review. The article, authored by Avalon Health Economics (Avalon), compares MyoStrain to Echocardiography (ECHO), the most...
June 19, 2019
We're here to answer your questions. Learn how MyoStrain can help transform your cardiac practice.
